bananasummer4
About
IMbrave 151: a randomized phase II tryout associated with atezolizumab combined with bevacizumab and also chemotherapy in individuals using advanced biliary region cancers.
IMbrave 151: a randomized phase II tryout associated with atezolizumab combined with bevacizumab and also chemotherapy in individuals using advanced biliary region cancers.